These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11170645)

  • 1. 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
    Salmon-Chemin L; Buisine E; Yardley V; Kohler S; Debreu MA; Landry V; Sergheraert C; Croft SL; Krauth-Siegel RL; Davioud-Charvet E
    J Med Chem; 2001 Feb; 44(4):548-65. PubMed ID: 11170645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase.
    Blumenstiel K; Schöneck R; Yardley V; Croft SL; Krauth-Siegel RL
    Biochem Pharmacol; 1999 Dec; 58(11):1791-9. PubMed ID: 10571254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
    Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
    J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi.
    Salmon-Chemin L; Lemaire A; De Freitas S; Deprez B; Sergheraert C; Davioud-Charvet E
    Bioorg Med Chem Lett; 2000 Apr; 10(7):631-5. PubMed ID: 10762041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships in 2-aminodiphenylsulfides against trypanothione reductase from Trypanosoma cruzi.
    Girault S; Davioud-Charvet E; Salmon L; Berecibar A; Debreu MA; Sergheraert C
    Bioorg Med Chem Lett; 1998 May; 8(10):1175-80. PubMed ID: 9871730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
    Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
    Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamine derivatives as inhibitors of trypanothione reductase and assessment of their trypanocidal activities.
    O'Sullivan MC; Zhou Q; Li Z; Durham TB; Rattendi D; Lane S; Bacchi CJ
    Bioorg Med Chem; 1997 Dec; 5(12):2145-55. PubMed ID: 9459012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease.
    Henderson GB; Ulrich P; Fairlamb AH; Rosenberg I; Pereira M; Sela M; Cerami A
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5374-8. PubMed ID: 3135548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma.
    De Gasparo R; Brodbeck-Persch E; Bryson S; Hentzen NB; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2018 May; 13(9):957-967. PubMed ID: 29624890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
    Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
    Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyamines with N-(3-phenylpropyl) substituents are effective competitive inhibitors of trypanothione reductase and trypanocidal agents.
    Li Z; Fennie MW; Ganem B; Hancock MT; Kobaslija M; Rattendi D; Bacchi CJ; O'Sullivan MC
    Bioorg Med Chem Lett; 2001 Jan; 11(2):251-4. PubMed ID: 11206471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds.
    Jockers-Scherübl MC; Schirmer RH; Krauth-Siegel RL
    Eur J Biochem; 1989 Mar; 180(2):267-72. PubMed ID: 2647489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
    Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Amino diphenylsulfides as inhibitors of trypanothione reductase: modification of the side chain.
    Baillet S; Buisine E; Horvath D; Maes L; Bonnet B; Sergheraert C
    Bioorg Med Chem; 1996 Jun; 4(6):891-9. PubMed ID: 8818240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
    Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
    Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
    Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
    Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB).
    da Paixão VG; Pita SSDR
    Comput Biol Chem; 2019 Apr; 79():36-47. PubMed ID: 30710804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.